Section 405(G) nonmotorized safety grant (23 C.F.R. & 1300.26; 23 U.S.C. & 405(G)) - grant to support enforcement of the state's laws applicable to pedestrian and bicycle safety through law…

The Texas Department of Transportation (TxDOT) received a $134,033.60 Formula Grant from the National Highway Traffic Safety Administration (NHTSA) under the National Priority Safety Programs (CFDA 20.616) on October 1, 2023. This grant will support TxDOT's efforts to enforce state laws applicable to pedestrian and bicycle safety through law enforcement training, enforcement mobilizations and campaigns, and public education and awareness programs. The 4-year grant period runs from October 2023 through September 2027. These Formula Grant funds are provided to states where the annual combined nonmotorized road user fatalities exceed 15% of the state's total annual crash fatalities, as determined by the NHTSA.

Section 405(G) nonmotorized safety grant (23 C.F.R. & 1300.26; 23 U.S.C. & 405(G)) - grant to support enforcement of the state's laws applicable to pedestrian and bicycle safety through law enforcement training, enforcement mobilizations and campaigns, and public education and awareness programs. 405(G) funding is available to qualifying states where the state's annual combined nonmotorized road user fatalities exceed 15 percent of the state's total annual crash fatalities based on the most recent calendar year for which final fars data are available, as determined by nhtsa. These funds are apportioned using statutory apportionment formula. These funds are provided to the state and territorial highway safety offices based on an approved triennial highway safety plan that details problem identification, public participation and engagement, performance measures, countermeasure strategies for programming funds and an approved annual grant application that details planned projects using identified countermeasure strategies for programming funds to help reduce crashes, injuries and fatalities resulting from motor vehicle crashes.